Rat 11β-hydroxysteroid dehydrogenase type 2 enzyme is expressed at low levels in the placenta and is modulated by adrenal steroids in the kidney

Molecular and Cellular Endocrinology

Volumn 120, Issue 1, 1996, Pages 67-75

  Li, Kevin X Z ^a   Smith, Robin E ^a   Ferrari, Paolo ^a   Funder, John W ^a   Krozowski, Zygmunt S ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

11 hydroxysteroid dehydrogenase; Gene expression; Kidney

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTICOSTEROID; DEOXYCORTICOSTERONE; DEXAMETHASONE; FLUDROCORTISONE; GLUCOCORTICOID; KIDNEY ENZYME; MINERALOCORTICOID RECEPTOR;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME REGULATION; FEMALE; FETUS; GENE EXPRESSION; GENE MUTATION; HORMONAL REGULATION; KIDNEY; MALE; NONHUMAN; NORTHERN BLOTTING; PAROTID GLAND; PLACENTA; PRIORITY JOURNAL; RAT;

EID: 0029973501     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/0303-7207(96)03822-1     Document Type: Article

References (46)

1. Krozowski, Z.S. and Funder, J.W. (1983) Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity. Proc. Natl. Acad. Sci. USA 80, 6056-6060.
2. Funder, J.W., Pearce, P.T., Smith, R. and Smith, A.I. (1988) Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242, 583-585.
3. Edwards, C.R., Stewart, P.M., Burt, D., Brett, L., McIntyre, M.A., Sutanto, W.S., deKloet E.R. and Monder, C. (1988) Localisation of 11 beta-hydroxysteroid dehydrogenase - tissue specific protector of the mineralocorticoid receptor. Lancet 2, 986-989.
4. Ulick, S., Levine, S.L., Gunczler, P., Zanconato, G., Ramirez, L., C, Rauh, W., Rosler, A., Bradlow, L.H. and New, M.I. (1979) A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J. Clin. Endocrinol. Metab. 49, 757-763.
5. Tedde, R., Pala, A., Melis, A. and Ulick, S. (1992) Evidence for cortisol as the mineralocorticoid in the syndrome of apparent mineralocorticoid excess. J. Endocrinol. Invest. 15, 471-474.
6. Albiston, A.L., Obeyesekere, V.R., Smith, R.E. and Krozowski, Z.S. (1994) Cloning and tissue distribution of the human 11beta-hydroxysteroid dehydrogenase type 2 enzyme. Mol. Cell. Endocrinol. 105, R11-R17.
7. Agarwal, A.K., Mune, T., Monder, C. and White, P.C. (1994) NAD(+)-dependent isoform of 11beta-hydroxysteroid dehydrogenase - cloning and characterization of cDNA from sheep kidney. J. Biol. Chem. 269, 25959-25962.
8. Naray-Fejes-Toth, A. and Fejes-Toth, G. (1995) Expression cloning of the aldosterone target cell-specific 11 beta-hydroxysteroid dehydrogenase from rabbit collecting duct cells. Endocrinology 136, 2579-2586.
9. Zhou, M.Y., Gomez-Sanchez, E.P., Cox, D.L., Cosby, D. and Gomez-Sanchez, C.E. (1995) Cloning, expression, and tissue distribution of the rat nicotinamide adenine dinucleotide-dependent 11 beta-hydroxysteroid dehydrogenase. Endocrinology 136, 3729-3734.
10. Whorwood, C.B., Mason, J.I., Ricketts, M.L., Howie, A.J. and Stewart, P.M. (1995) Detection of human 11 beta-hydroxysteroid dehydrogenase isoforms using reverse-transcriptase-polymerase chain reaction and localization of the type 2 isoform to renal collecting ducts. Mol. Cell. Endocrinol. 110, R7-R12.
11. Roland, B.L., Krozowski, Z.S. and Funder, J.W. (1995) Glucocorticoid receptor, mineralocorticoid receptors, 11 beta-hydroxysteroid dehydrogenase-1 and -2 expression in rat brain and kidney: in situ studies. Mol. Cell. Endocrinol. 111, R1-R7.
12. Krozowski, Z., Maguire, J.A., Stein-Oakley, A.N., Dowling, J., Smith, R.E. and Andrews, R.K. (1995) Immunohistochemical localization of the 11 beta-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta. J. Clin. Endocrinol. Metab. 80, 2203-2209.
13. Edwards, C., Benediktsson, R., Lindsay, R.S. and Seckl, J.R. (1993) Dysfunction of placental glucocorticoid barrier - link between fetal environment and adult hypertension. Lancet 341, 355-357.
14. Wilson, R.C., Krozowski, Z.S., Li, K., Obeyesekere, V.R., Razzaghyazar, M., Harbison, M.D., Wei, J.Q., Shackleton, C., Funder, J.W. and New, M.I. (1995) A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess. J. Clin. Endocrinol. Metab. 80, 2263-2266.
15. Mune, T., Rogerson, F.M., Nikkila, H., Agarwal, A.K. and White, P.C. (1995) Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase. Nat. Genet. 10, 394-399.
16. Wilson, R.C., Harbison, M.D., Krozowski, Z.S., Funder, J.W., Shackleton, C., Hanauskeabel, H.M., Wei, J.Q., Hertecant, J., Moran, A., Neiberger, R.E., Balfe, J.W., Fattah, A., Daneman, D., Licholai, T. and New, M.I. (1995) Several homozygous mutations in the gene for 11 beta-hydroxysteroid dehydrogenase type 2 in patients with apparent mineralocorticoid excess. J. Clin. Endocrinol. Metab. 80, 3145-3150.
17. Stewart, P.M., Krozowski, Z.S., Gupta, A., Milford, D.V., Howie, AJ., Sheppard, M.C. and Whorwood, C.B. (1996) Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11 beta-hydroxysteroid dehydrogenase type 2 gene. Lancet 347, 88-91.
18. Rundle, S., E, Funder, J., W, Lakshmi, V. and Monder, C. (1989) The intrarenal localization of mineralocorticoid receptors and 11-beta dehydrogenase: immunocytochemical studies. Endocrinology 125, 1700-1704.
19. Tannin, G.M., Agarwal, A.K., Monder, C., New, M.I. and White, P.C. (1991) The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization. J. Biol. Chem. 266, 16653-16658.
20. Yang, K. (1995) Ovine 11 beta-hydroxysteroid dehydrogenase: from gene to function. Endocr. Res. 21, 367-377.
21. Nikkila, H., Tannin, G.M., New, M.I., Taylor, N.F., Kalaitzoglou, G., Monder, C. and White, P.C. (1993) Defects in the HSD11 gene encoding 11-beta-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxoreductase deficiency. J. Clin. Endocrinol. Metab. 77, 687-691.
22. Chirgwin, J.M., Pryzbyla, A.E., MacDonald, R.J. and Rutter, W.J. (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294-5299.
23. Krozowski, Z., Obeyesekere, V., Smith, R. and Mercer, W. (1992) Tissue-specific expression of an 11 beta-hydroxysteroid dehydrogenase with a truncated N-terminal domain. A potential mechanism for differential intracellular localization within mineralocorticoid target cells. J. Biol. Chem. 267, 2569-2574.
24. Lim, A.T., Khalid, B.A., Clements, J. and Funder, J.W. (1982) Glucocorticoid and mineralocorticoid effects on adrenocorticotropin and beta-endorphin in the adrenalectomized rat. J. Clin. Invest. 69, 1191-1198.
25. Bradford, M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein dye binding. Anal. Biochem. 72, 248-254.
26. Cole, T.J. (1995) Cloning of the mouse 11 beta-hydroxysteroid dehydrogenase type 2 gene: tissue specific expression and localization in distal convoluted tubules and collecting ducts of the kidney. Endocrinology 136, 4693-4696.
27. Agarwal, A.K., Rogerson, F.M., Mune, T. and White, P.C. (1995) Gene structure and chromosomal localization of the human HSD11k gene encoding the kidney (type 2) isozyme of 11 beta-hydroxysteroid dehydrogenase. Genomics 29, 195-199.
28. Walker, B.R., Williams, B.C. and Edwards, C. (1994) Regulation of 11 beta-hydroxysteroid dehydrogenase activity by the hypothalamic-pituitary-adrenal axis in the rat. J. Endocrinol. 141, 467-472.
29. Krozowski, Z. (1992) 11-beta-Hydroxysteroid dehydrogenase and the short-chain alcohol dehydrogenase (SCAD) superfamily. Mol. Cell. Endocrinol. 84, C25-C31.
30. Mercer, W.R. and Krozowski, Z.S. (1992) Localization of an 11 beta-hydroxysteroid dehydrogenase activity to the distal nephron. Evidence for the existence of two species of dehydrogenase in the rat kidney. Endocrinology 130, 540-543.
31. Yang, K. and Matthews, S.G. (1995) Cellular localization of 11 beta-hydroxysteroid dehydrogenase 2 gene expression in the ovine adrenal gland. Mol. Cell. Endocrinol. 111, R19-R23.
32. Roland, B.L and Funder, J.W. (1996) Localization of 11-beta-Hydroxysteroid dehydrogenase type 2 in rat tissues: in situ studies. Endocrinology 137, 1123-1128.
33. Albiston, A.L., Smith, R.E. and Krozowski, Z.S. (1995) Sex-and tissue-specific regulation of 11 beta-hydroxysteroid dehydrogenase mRNA. Mol. Cell. Endocrinol. 109, 183-188.
34. Hierholzer, K., Siebe, H. and Fromm, M. (1990) Inhibition of 11 beta-hydroxysteroid dehydrogenase and its effect on epithelial sodium transport. Kidney Int. 38, 673-678.
35. Whorwood, C.B., Ricketts, M.L. and Stewart, P.M. (1994) Epithelial cell localization of type 2 11 beta-hydroxysteroid dehydrogenase in rat and human colon. Endocrinology 135, 2533-2541.
36. Burton, P.J. and Waddell, B.J. (1994) 11 beta-hydroxysteroid dehydrogenase in the rat placenta: developmental changes and the effects of altered glucocorticoid exposure. J. Endocrinol. 143, 505-513.
37. Low, S.C., Chapman, K.E., Edwards, C., Wells, T., Robinson, I. and Seckl, J.R. (1994) Sexual dimorphism of hepatic 11 beta-hydroxysteroid dehydrogenase in the rat: the role of growth hormone patterns. J. Endocrinol. 143, 541-548.
38. Lax, E.R., Ghraf, R. and Schriefers, H. (1978) The hormonal regulation of hepatic microsomal 11-beta-hydroxysteroid dehydrogenase activity in the rat. Acta Endocrinol. (Cph.) 89, 352-358.
39. Low, S.C., Moisan, M.P., Noble, J.M., Edwards, C. and Seckl, J.R. (1994) Glucocorticoids regulate hippocampal 11 beta-hydroxysteroid dehydrogenase activity and gene expression in vivo in the rat. J. Neuroendocrinol. 6, 285-290.
40. Siebe, H., Baude, G., Lichtenstein, I., Wang, D., Buhler, H., Hoyer, G.A. and Hierholzer, K. (1993) Metabolism of dexamethasone - sites and activity in mammalian tissues. Renal Physiol. Biochem. 16, 79-88.
41. Ferrari, P., Smith, R.E., Funder, J.W. and Krozowski, Z.S. (1996) Substrate and inhibitior specificity of the cloned human 11 β-hydroxysteroid dehydrogenase type 2 isoform. Am. J. Physiol. (in press).
42. Monder, C. and Lakshmi, V. (1989) Evidence for kinetically distinct forms of corticosteroid 11 beta-dehydrogenase in rat liver microsomes. J. Steroid Biochem. 32, 77-83.
43. Lakshmi, V., Nath, N. and Muneyyircidelale, O. (1993) Characterization of 11-beta-hydroxysteroid dehydrogenase of human placenta - evidence for the existence of two species of 11-beta-hydroxysteroid dehydrogenase. J. Steroid Biochem. Mol. Biol. 45, 391-397.
44. Oelkers, W., Buchen, S., Diederich, S., Krain, J., Muhme, S. and Schoneshofer, M. (1994) Impaired renal 11β-oxidation of 9alpha-fluorocortisol: an explanation for its mineralocorticoid potency. J. Clin. Endo. Metab. 78, 928-932.
45. Funder, J.W., Pearce, P.T., Myles, K. and Roy, L.P. (1990) Apparent mineralocorticoid excess, pseudohypoaldosteronism, and urinary electrolyte excretion: toward a redefinition of mineralocorticoid action. FASEB J. 4, 3234-3238
46. Naray-Fejes-Toth, A. and Fejes-Toth, G. (1990) Glucocorticoid receptors mediate mineralocorticoid-like effects in cultured collecting duct cells. Am. J. Physiol. 259, F672-F678.